loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 61639 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ERYTHROMYCIN ETHYLSUCCINATE (2)

filter

01 ARBOR PHARMS LLC (2)

filter

01 SUSPENSION;ORAL (2)

filter

01 EQ 200MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 EQ 400MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
SUSPENSION;ORAL
EQ 200MG BASE/5ML **Fe...
E.E.S. 200
USA
61639
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION;ORAL
EQ 400MG BASE/5ML **Fe...
E.E.S. 400
USA
61639
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 61639

Looking for CTD TGA MCC DOSSIER APPLICATION 61639 2

19

Arbor Pharmaceuticals, based in U.S.A, is a pharmaceutical company.

One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 61639 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

Arbor Pharmaceuticals's E.E.S. 200 SUSPENSION;ORAL, medication with EQ 200MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ERYTHROMYCIN ETHYLSUCCINATE.

18

Arbor Pharmaceuticals, based in U.S.A, is a pharmaceutical company.

One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 61639 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

Arbor Pharmaceuticals's E.E.S. 400 SUSPENSION;ORAL, medication with EQ 400MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ERYTHROMYCIN ETHYLSUCCINATE.

Post Enquiry
POST ENQUIRY